Aussies stunned by ‘fireball' meteor
The bright fireball passed through the skies about 6am on Sunday over the Central Wheatbelt, producing a brilliant yellow flash and a trail of bright green.
Witnesses were able to catch a glimpse of the early-morning meteor from Perth to the Goldfields, however, experts are yet to determine where it eventually landed.
The Perth Observatory said the astronomical sight was 'most likely an iron meteor' which had been 'orbiting within the inner Solar System'.
'To shine that brightly, the fireball — technically known as a bolide — would have been about the size of a cricket ball to a basketball,' the observatory said online.
According to Perth Observatory's Matthew Woods, the meteor would have been travelling between 16 to 60km per second, leaving behind a trail of green as the built-up friction melted.
He told 9News it was 'one hell of a meteor'.
'That was very nice … little surprise for Mother's Day,' he said.
Online, witnesses were dumbfounded by the 'spectacular' sight, with some believing it was an aeroplane.
'Never seen anything like it,' one person wrote.
'Thought someone was driving at us with high beams on at first,' said another, who watched it pass overhead from Newdegate.
A resident from Mt Magnet said they initially thought the 'huge and burning bright orange-red' light was 'the moon until it moved'.
Some thought the meteor was the Kosmos 482, a Soviet-era spacecraft that plunged back to earth more than 50 years after its failed launch to Venus.
However, Curtin University astrophysicist Steven Tingay told the ABC it was unlikely the fallen spacecraft, which likely landed over the Indian Ocean on Saturday, though European and US agencies are yet to confirm its exact location.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Medscape
4 hours ago
- Medscape
These Markers May Predict Risk for Bone Loss in SLE
TOPLINE: Osteoporosis was prevalent in 41% of patients with systemic lupus erythematosus (SLE). Factors such as lupus nephritis classes III and IV, U1-ribonucleoprotein (RNP) antibodies, and longer disease duration were associated with lower areal bone mineral density (BMD), and active lupus nephritis was associated with osteoporosis. METHODOLOGY: Researchers analysed data of a subcohort of patients from a prospective observational study to identify factors associated with BMD and the risk for osteoporosis. They included 110 patients with SLE (mean age, 48 years; 92% women) from a hospital in Berlin between July 2015 and January 2022 who fulfilled the American College of Rheumatology/ European League Against Rheumatism 2019 SLE classification criteria and had current or prior glucocorticoid treatment. The analysis included SLE disease activity and a standardised bone health assessment with the DEXA scan and trabecular bone score measurement according to national guidelines. BMD- and osteoporosis-related factors were assessed. The following three co-primary endpoints were assessed: Areal BMD, expressed as the lowest DEXA-derived T score at the lumbar spine (L1-L4), total hip, or femoral neck A composite osteoporosis outcome (a femoral or lumbar spine T score ≤ -2.5 and/or history of a major fragility fracture and/or antiosteoporotic treatment) The prevalence of fragility fractures (any, vertebral, and non-vertebral). TAKEAWAY: Overall, 41% and 35% of patients with SLE had osteoporosis and lupus nephritis, respectively. Factors significantly associated with lower areal BMD included lupus nephritis classes III and IV (P = .025), U1-RNP antibodies (P = .009), higher C-reactive protein levels (P = .015), and longer disease duration (P = .001). Clinical remission (P = .033) and higher Health Assessment Questionnaire scores (P = .009) were positively correlated with areal BMD. Active lupus nephritis was strongly associated with osteoporosis in patients with SLE (odds ratio [OR], 7.42; P = .027), along with other factors such as older age (OR, 1.06; P = .003) and lower Health Assessment Questionnaire scores (OR, 0.29; P = .005). IN PRACTICE: "The identification of SLE-specific risk factors allows us to recognize patients at particular high risk for OP [osteoporosis]. This prompts us to suggest a thorough osteoporosis check-up in patients with high CRP [C-reactive protein], LN [lupus nephritis], or U1-RNP-antibodies," the authors wrote. SOURCE: This study was led by Edgar Wiebe, Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Department of Rheumatology and Clinical Immunology, Charitéplatz 1, Berlin, Germany. It was published online on July 28, 2025, in Arthritis Research & Therapy. LIMITATIONS: This monocentric cohort study primarily involved White Caucasians, thereby limiting the generalisability of the findings to other patient groups. A potential selection bias may have resulted in overrepresentation of patients with more severe disease courses who were at a high risk for osteoporosis. The cross-sectional design limited the ability to establish causality between identified factors and outcomes. DISCLOSURES: Open access funding was enabled and organised by Projekt DEAL. The prospective observational study received a joint funding from AbbVie, Amgen, Alfasigma, Almirall, Biogen, BMS, Chugai, Fresenius Kabi, Galapagos, GA Generic Assays, GSK, Hexal, Horizon Therapeutics, Lilly, Medac, Mundipharma, Novartis, Pfizer, Roche, Sanofi-Genzyme, and UCB. The authors declared having no conflicts of interest. This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.
New York Post
20 hours ago
- New York Post
Radioactive wasp nests at SC nuclear weapons site raise worries about possible contamination, leaks
The buzz about radioactive wasps at a Cold War-era nuclear site in South Carolina just won't die. Investigators found 'hot' nests inside a nuclear weapons facility in South Carolina, with scientists warning it could be evidence of a possible leak or contamination that wasn't previous detected. The US Department of Energy said the nests are not believed to pose a risk to workers or the surrounding community. Advertisement 'This is an indicator that there are contaminants spread across this area that have not been completely encased and protected,' Dr. Timothy Mousseau, a biologist at the University of South Carolina, told the New York Times. 4 Employees who routinely check radiation levels at the Savannah River Site near Aiken found a wasp nest on July 3. AP A total of four contaminated nests have now been found at the facility near Aiken, around 20 miles east of Augusta, Georgia, according to federal officials. Advertisement A first nest was discovered by workers at the Savannah River Site (SRS) — which produced material for nuclear weapons during the Cold War — in early July, as disclosed in a report from the Department of Energy, which owns the site. The discovery of a further three radioactive wasp nests 'indicate[s] that much greater effort must be made to assess the possible risks and hazards of what appears to be a significant source of radioactive pollutants,' Mousseau, who has studied the effect of radiation on wildlife in Chernobyl and Fukushima, told the Times. 'This could indicate that there is some new or old radioactive contamination that is coming to the surface that was unexpected,' he said. Wasps usually don't venture farther than 100 yards from their nests — so Mousseau said the risk of a member of the public being stung by a radioactive wasp is low. Advertisement He suggested that one simple explanation for the radiation readings on that nest is that the insects found a discarded piece of contaminated wood and used some of the pulp to build their nests This isn't the first time evidence of contamination of local wildlife was found at the site. 4 The workers sprayed the nest with insect killer, removed it and disposed of it as radioactive waste. andRiU – In 2017, radioactive bird droppings were discovered on the roof of a building at the site, raising fears the animals were carrying nuclear contamination over large distances, according to a Department of Energy report at the time. Advertisement Officials say the radiation levels in the nests are low, and no risk is posed to workers. 4 The nest had a radiation level 10 times what is allowed by federal regulations, officials said. Getty Images/fStop 'The US Department of Energy is managing the discovery of four wasp nests with very low levels of radioactive contamination,' the manager of the Energy Department's office at Savannah River, Edwin Deshong, said in a statement. 'The nests do not pose a health risk to SRS workers, the community, or the environment,' he said. Workers at the site uncovered the first radioactive wasp nest close to a tank used to store nuclear waste. 4 If there had been wasps found, they would have significantly lower levels of radiation than their nests. ptoscano – 'The wasp nest was sprayed to kill wasps, then bagged as radioactive waste,' the federal report read. 'The ground and surrounded area did not have any contamination.' Advertisement The Savannah River Site was built in the 1950s at the start of the Cold War to produce materials for nuclear and hydrogen weapons, including plutonium and tritium. After the end of the Cold War, production of material for nuclear weapons slowed down considerably. In 1996, the Department of Energy began cleaning up the site, although progress has been slow. Cleanup is not expected to be completed until 2065, according to the Department of Energy.
Yahoo
2 days ago
- Yahoo
Natera initiates trial of Signatera test for breast cancer
Natera has announced the initiation of the Phase II TEODOR trial of its Signatera test aimed at replacing chemotherapy with endocrine therapy before surgery in certain breast cancer patients. The multicentre, randomised controlled trial (RCT) focuses on women with hormone receptor-positive (HR+), human epidermal growth factor receptor 2 (HER2)-negative breast cancer who are responsive to endocrine treatment and test negative with Signatera. Academic research organisation Austrian Breast & Colorectal Cancer Study Group sponsored the trial, which plans to enrol 250 subjects across 15 Austrian sites. This trial seeks to assess the endocrine therapy's efficacy in comparison to chemotherapy in those who are Signatera-negative, to minimise the use of pre-operative chemotherapy and its associated side effects. After receiving an endocrine therapy course for four weeks, subjects who remain Signatera-negative and exhibit a favourable response as per the Ki-67 proliferation index measurement are set to be randomised to continue with endocrine therapy or chemotherapy. The primary goal of the TEODOR trial is the response rate to neoadjuvant therapy, gauged by pathological complete response (pCR) and modified Preoperative Endocrine Prognostic Index (PEPI) score, across endocrine and chemotherapy trial arms. Secondary goals encompass long-term effects such as recurrence of breast cancer and overall survival rates. Signatera is a custom-built blood test for identifying molecular residual disease (MRD) in the form of circulating tumour DNA. Natera oncology medical director Angel Rodriguez said: 'With the TEODOR trial, our goal is to identify patients who may be able to safely forgo chemotherapy. 'We are proud to collaborate with ABCSG on this important trial, and we hope this study will support the role of Signatera in guiding neoadjuvant therapy in breast cancer.' The test is covered by Medicare for those with stage IIb and higher breast cancer. In May 2025, Natera announced outcomes from a study assessing the Signatera MRD test in those with soft tissue and bone sarcomas. "Natera initiates trial of Signatera test for breast cancer" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
